Table 3.
Overall (N = 6,751) | Fully Vaccinated (N = 1,779) | In Vaccination Window (N = 1,420) | Before Vaccination (N = 3,552) | p-Value | |
---|---|---|---|---|---|
Vaccine reaction | 1.1% | 2.1% | 2.4% | 0.0% | <0.001 |
Allergic reaction | 0.1% | 0.4% | 0.3% | 0.0% | <0.001 |
Adverse reaction | 0.1% | 0.2% | 0.3% | 0.0% | 0.011 |
COVID-19 complication | 4.1% | 1.6% | 4.2% | 5.4% | <0.001 |
SARS-CoV-2 infection | 4.1% | 1.6% | 4.2% | 5.4% | <0.001 |
Acute respiratory failure | 0.3% | 0.1% | 0.2% | 0.5% | 0.035 |
History of COVID-19 | 2.2% | 2.0% | 2.1% | 2.3% | 0.818 |
COVID-19 exposure | 24.2% | 25.1% | 23.5% | 24.0% | 0.540 |
Boldface type denotes statistical significance. COVID-19 = coronavirus disease 2019; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.